LGC acquires The Native Antigen Company
The acquisition aims to strengthen LGC’s existing product offering to the in vitro diagnostics sector
The acquisition aims to strengthen LGC’s existing product offering to the in vitro diagnostics sector
Explore the techniques and technologies that are shaping the latest advancements in cancer research
Dr. Pierre Cordelier describes how some exciting pre-clinical data suggests oncolytic viruses could tackle pancreatic cancer
The FT819 CAR T cell line has the potential to be mass-produced, stored, and made readily available for cancer immunotherapy
Study demonstrates that the test can add prognostic information on overall survival
Institut Curie is one of an increasing number of major European cancer centers to become a co-validation partner for the new NGS-based MammaPrint BluePrint Kit
Financial support will accelerate researching new drugs to battle aggressive blood, brain and breast cancers
Dr. Stephen Chanock, National Cancer Institute, shares the latest cancer epidemiology studies at the NIH and the team’s hopes of being able to predict and prevent disease
InSphero and NCATS to Present Collaborative 3D Cancer Screening Study at SLAS2016 Annual Meeting